We are live on ! Find out more
PYXS icon

Pyxis Oncology

99 hedge funds and large institutions have $49.2M invested in Pyxis Oncology in 2024 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,884% more call options, than puts

Call options by funds: $1.59M | Put options by funds: $80K

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

83% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 18

8% more funds holding

Funds holding: 92 → 99 (+7)

6.13% more ownership

Funds ownership: 46.93% → 53.06% (+6.1%)

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

53% less capital inflows, than outflows

Capital inflows: $13.3M | Capital outflows: $28.3M

Holders
99
Holders Change
+7
Holders Change %
+7.61%
% of All Funds
1.3%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
19
Increased
33
Reduced
18
Closed
19
Calls
$1.59​M
Puts
$80​K
Net Calls
+$1.51​M
Net Calls Change
-⁠$238​K

PYXS Hedge Fund Activity: Q4 2024 in Review

99 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q4 2024, worth a combined $49.2M — down 52% from $102M a quarter earlier.

Fund positioning in PYXS was balanced in Q4 2024: 19 funds opened new positions, 19 closed out, 33 added to existing stakes and 18 trimmed.

The largest buyer was Millennium Management, adding an estimated $3.1M. The largest seller was Deep Track Capital, exiting entirely with an estimated $15.4M sold.

  • 99 institutional investors held Pyxis Oncology (PYXS) as of Q4 2024, up from 92 in Q3 2024.
  • Funds reported $49.2M of Pyxis Oncology stock for Q4 2024, down 52% quarter-over-quarter.
  • 19 funds opened new Pyxis Oncology positions in Q4 2024 and 19 closed out, a net change of 0 holders.
  • The largest Pyxis Oncology buyer in Q4 2024 was Millennium Management, an estimated $3.1M added.
  • The largest Pyxis Oncology seller in Q4 2024 was Deep Track Capital, an estimated $15.4M sold.

Based on aggregated 13F filings for Q4 2024.